Toggle light / dark theme

Battery technology is undergoing a rapid evolution. Recent years have seen significant improvements in both range and charging speed for EVs. BYD and CATL’s upcoming batteries are the latest example, aiming to revolutionize charging times. These companies are reportedly set to debut their ultra-fast-charging LFP batteries by the end of this year, potentially eliminating the need for lengthy charging stops during road trips.

The key to these rapid charge times lies in the 6C charging rate boasted by both the BYD Blade 2.0 and CATL Qilin 2.0 battery packs. In simpler terms, the “6” signifies that the charging multiplier is six times the battery capacity. For instance, a 100-amp-hour battery could be charged with a massive 600-amp current.

However, there are hurdles to overcome. Upgrading the charging infrastructure is crucial to support these speeds. Without an update to the charging network, owners of these advanced batteries won’t be able to fully benefit from their technology and will be limited by slower charging options. It’s also important to remember that batteries can’t maintain peak charging speeds throughout the entire charging cycle. Expect some strategic marketing around these new batteries, with a focus on specific charging windows, like 10% to 80% in 10 minutes. The 2024 Zeekr 1 with its 5C-rated battery is a prime example, achieving an 11.5-minute charge time for this range.

“The Uncanny Valley” published by Masahiro Mori in 1970 explores how our affinity for robots changes as they become more human-like.

This paper has had a big impact on human-computer interaction and is especially relevant today’s #AI landscape.


Fermat’s Library is a platform for illuminating academic papers.

Those who rush to leverage AI’s power without adequate preparation face difficult blowback, scandals, and could provoke harsh regulatory measures. However, those who have a balanced, informed view on the risks and benefits of AI, and who, with care and knowledge, avoid either complacent optimism or defeatist pessimism, can harness AI’s potential, and tap into an incredible variety of services of an ever-improving quality.

These are some words from the introduction of the new book, “Taming the machine: ethically harness the power of AI”, whose author, Nell Watson, joins us in this episode.

Nell’s many roles include: Chair of IEEE’s Transparency Experts Focus Group, Executive Consultant on philosophical matters for Apple, and President of the European Responsible Artificial Intelligence Office. She also leads several organizations such as EthicsNet.org, which aims to teach machines prosocial behaviours, and CulturalPeace.org, which crafts Geneva Conventions-style rules for cultural conflict.

Selected follow-ups:

I think this could lead to immortality basically allowing for limited growth of dna structures but still offering unlimited lifespan. In short this also prevents cancer aswell.


Telomerase is a ribonuceloprotein complex responsible for maintaining telomeres and protecting chromosomal integrity. The human telomerase reverse transcriptase (hTERT) is expressed in ∼90% of cancer cells where it confers the capacity for limitless proliferation. Along with its established role in telomere lengthening, telomerase also serves noncanonical extra-telomeric roles in oncogenic signaling, resistance to apoptosis, and enhanced DNA damage response. We report a new class of natural-product-inspired covalent inhibitors of telomerase that target the catalytic active site.

This also an amazing supplement that also exists in all foods called nad plus that stops age related symptoms.


Nicotine, a metabolite of the NAD+ metabolic pathway, has been found to possess anti-inflammatory and neuroprotective properties, yet the underlying molecular mechanisms remained unknown. Here, the authors show that low-dose nicotine promotes SIRT1 deacetylation of NAMPT and enhanced NAMPT activity which boosts NAD generation and improves age related symptoms.

Though hardly conclusive, this study strongly suggests that boosting NAD+ levels in humans could have incredible health benefits.

That’s where Basis comes in.

Created by Elysium Health, Basis is a proprietary formulation of crystalline nicotinamide riboside and pterostilbene, which the human body converts into NAD+. In a double-blind, randomized, placebo-controlled clinical trial, it was demonstrated that, on average, Basis increases NAD+ levels by 40 percent. These elevated NAD+ levels won’t necessarily stop the aging process. But they will certainly maximize cellular health, boost energy, and support healthy sleep. This in turn should allow people who are in good health to maintain it longer, and thus age better.

Ronald Rael and Virginia San Fratello may have met as graduate students in architecture at Columbia University, but it quickly became clear that “architecture” would prove an inadequate term to describe their eclectic body of work.

As the pair started working together in 2002, they became increasingly aware that “sometimes the forces that enable architecture, chiefly capitalism, can corrupt the architect’s social agenda,” Rael says. “This became the impetus to rethink how and why architecture should be created.”